Research has shown that organophosphorus pesticides impair glucose homeostasis and cause insulin resistance and type 2 diabetes. The current study investigates the influence of phoxim on insulin signaling pathways and the protective effects of vitamin E. Phoxim (180 mg kg −1 ) and VE (200 mg kg −1 ) were administered orally to Sprague-Dawley rats over a period of 28 consecutive days. After exposure to phoxim, the animals showed glucose intolerance and hyperinsulinemia during glucose tolerance tests, and insulin tolerance tests demonstrated an impaired glucose-lowering effect of insulin. Phoxim increases the fasting glucose, insulin and cholesterol levels, as well as the liver hexokinase activity (HK) significantly while decreasing the high density lipoprotein (HDL) cholesterol, and glycogen content in the liver and skeletal muscles observably. Furthermore, we observed an increase of insulin resistance biomarkers and a decrease of insulin sensitivity indices. The insulin receptor substrate (IRS)-2 mRNA expressions of liver and skeletal muscles were down-regulated by phoxim, while the expression of IRS-1 showed no difference.
Introduction
Organophosphorus pesticides (OPs) are broad-spectrum insecticides employed to prevent, control and eradicate the spread of highly lethal parasitic diseases. The use of OPs has increased considerably due to their low toxicity and low persistence in mammalian systems compared to organochlorine pesticides. 1 With the indiscriminate use of insecticides in the fields, exposure to OPs causes deleterious effects in animals, as well as other environmental and ecological adverse impact. 2, 3 The main mechanism of action of OPs is the inhibition of the enzyme acetylcholinesterase (AChE), which results in signs and symptoms of excessive cholinergic stimulation. 4 OPs may induce oxidative stress leading to the generation of free radicals and alteration in antioxidants or oxygen free radical scavenging enzyme systems. 5, 6 Reviews also reported that OPs impair glucose homeostasis and cause insulin resistance and type 2 diabetes. 7, 8 Phoxim (o,o-diethyl phosphorothioate) is an effective OP pesticide used widely throughout the world for agricultural and domestic purposes, and in veterinary medicine. 5 Li et al. 9 indicated that phoxim dysregulated the expression of IIS pathway genes and induced abnormal nutrient metabolism in the silkworm midgut. Our previous research found that phoxim induced hepatic injury, oxidative stress damage, and cell apoptosis by elevated liver coefficient, ROS, some biochemical parameters (GGT, AST, ALP, TBIL, TBA, and ALT), as well as the expression of apoptosis genes (p53, Bax, caspase-9, caspase-8, and caspase-3). However, phoxim caused a reduction of TP, ALB, ChE, AChE, T-AOC, GSH-Px, and GSH and the expression of Bcl-2. 10 Recently, most of the studies have found that phoxim exposure may affect the growth, reproduction, normal physiology, oxidative stress and gene expression in Bombyx mori. [11] [12] [13] [14] [15] [16] However, few studies have investigated phoxim exposure in mammals, such as phoximinduced change in glucose metabolism in rats.
Several nutrients have modifying effects on the toxicity of contaminants. For example, vitamin E, a major lipid-soluble antioxidant present in all cellular membranes, plays a significant protective role against oxidative stress and prevents the production of lipid peroxides by scavenging free radicals in biological membranes. 17, 18 In vivo and in vitro, supplementation with vitamin E alleviate the toxicity induced by chlorpyrifos and fenitrothion. [19] [20] [21] [22] [23] Researchers have also reported that vitamin E supplementation counteracts inhibited Atlantic salmon carbohydrate metabolism induced by chlorpyrifos. 24 Vitamin E had scavenging the effect of reactive oxygen species (ROS) in the pancreatic islets, and resulted in improvements of glucose tolerance and diabetic control. 25 Above all, we planned to investigate whether vitamin E can ameliorate the phoximinduced change of glucose metabolism and mRNA expression of IRS-2 in the liver and muscles of rats.
Materials and methods
Chemical Phoxim (92%) was obtained from the Hubei Dixin Chemical Manufacturing Co., Ltd (Wuhan, China).
Animals
Five-week-old male Sprague-Dawley rats weighing 130 to 150 g were purchased from Harbin Medical University Laboratory Animal Center (Harbin, China), housed three per cage in clean plastic cages and allowed to acclimatize in the laboratory environment for a week. Animals were maintained under a controlled temperature (25 ± 2°C) and humidity (50 ± 5%), in a mass air displacement room with a 12 h light and dark cycle. The animal had unlimited access to food and drinking water. All of the animal experimental procedures were performed in strict accordance with the guidelines of the National Research Council Guide (1996) . The study was approved by the Ethical and Animal Welfare Committee of Heilongjiang Province, China (2008) and the Animal Care and Use Committee of Northeast Agriculture University, Harbin, China (2013).
Experimental design

Determination of optimum dose
The choice of phoxim dose was based on previous reports and corresponds to an acceptable dose that did not cause any sign of toxicity until the end of the experiment period. The used dose of phoxim was calculated directly from commercial grade products and corresponds to 1/12LD50 (LD50 = 2170 mg kg −1 of body weight of the rat 26 ).
The dose of vitamin E was selected on the basis of previously published reports suggesting that vitamin E was not toxic to humans or animals at this dose. Furthermore, vitamin E does not show any signs of toxicity at doses even higher than the one administered in the present study.
Animal treatment
Thirty-six Sprague-Dawley rats were divided into three groups of 12 rats each: control (CTR), phoxim only (Phoxim) and phoxim plus vitamin E (Phoxim + VE). All animals were treated via oral gavage once a day for 28 consecutive days. Phoxim (180 mg per kg of body weight) and vitamin E (200 mg per kg of body weight) dissolved in soybean oil (100%), respectively, were administered during the experimental period. Phoxim and vehicle were administered in the morning between 08:00 and 09:00.
Glucose tolerance test and insulin tolerance test
The glucose tolerance test was conducted on the 21 st day. After 12 h of fasting, the oral glucose tolerance test (OGTT) was conducted in both the control and treated rats. Blood samples were collected from the tail veins of rats, (control and treated groups) which were fasted overnight to baseline blood glucose levels. Subsequently, rats of both the control and treated groups were orally administered 20% glucose solution (2 g per kg of body weight). Blood was collected from the tail veins of these rats at 30 min intervals for 3 h for the estimation of glucose. For the insulin tolerance test (ITT), rats were injected with 0.75 U human insulin per kg of body weight (Novolin R; Novo Nordisk, Copenhagen, Denmark). Blood samples were collected after 0, 15, 30, 45 and 60 minutes. Blood glucose was estimated using a commercial glucometer (Accu-Check, Roche Diagnostics, Shanghai, China).
Sampling
The fasted animals (12 h of fasting) were decapitated without preliminary anesthesia on the 28 th day. Arteriovenous blood was quickly collected in clean plastic tubes. Serum was immediately separated by centrifuging at 3000g for 15 min and used for determining the glycaemia and insulinemia dosage. At the same time, the liver and skeletal muscles were removed, blood was cleared off and they were immediately divided into two parts. One part of the tissue was stored at −20°C and used for glycogen and enzyme activity analysis, while the remaining part was frozen in liquid nitrogen and stored at −80°C for use in gene expression analysis.
Biochemical determination
Serum glucose levels. The serum glucose was determined with an automated biochemical analyzer (Synchron CX®4 Pro Beckman Coulter, USA) using commercial diagnostics kits (Biosino Biotechnology & Science INC, Beijing, China).
Serum lipid levels. For the determination of serum total cholesterol (TC), LDL, HDL and TG concentrations, the corresponding diagnostic kits, set by Biosino Biotechnology and Science Inc. (China), were used according to the manufacturer's instructions.
Enzyme-linked immunosorbent assay
Commercial reagent kits for insulin and glucagon were obtained from the Experimental Equipment Co., Ltd of Shanghai Jinma (Shanghai, China). Briefly, 50 µl serum samples were added and analyzed, in duplicate, on each plate according to the specific time points studied. Samples were incubated at room temperature for 2 h followed by repeated washes. The substrate was added for 15 min. The absorbance was read at 450 nm using a microplate reader. The recombinant rat insulin and glucagon were used as standards, and the results were expressed as mU of insulin per l, and ng of glucagon per ml. All of the tests were performed using four independent replicates.
Glycogen
The glycogen content of the liver and skeletal muscles was determined using a commercial kit (Bioengineering Company of Nanjing Jiancheng, Nanjing, China). Briefly, 0.1 g of the liver or skeletal muscles was extracted with 0.3 ml of 30% KOH, incubated for 5 min at 100°C. With the addition of concentrate H 2 SO 4 , glycogen was broken down into furfural derivatives, which can form blue compounds when combined with anthranone. The absorbance was measured at 620 nm using an ultraviolet spectrophotometer (UV-2410PC model, Shimadzu, Japan). The results are expressed in mg of glycogen per 1 g of the liver or skeletal muscles.
Enzyme activity
Liver and skeletal muscle tissue homogenates (10%) were prepared using chilled normal saline. Hexokinase (HK) activities were determined using a commercial regent kit (Bioengineering Company of Nanjing Jiancheng, Nanjing, China). The absorbance was measured at 340 nm using an ultraviolet spectrophotometer (UV-2410PC model, Shimadzu, Japan). The HK activity was expressed as nmmol nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) generated per min per g of tissue protein.
Insulin resistance and insulin sensitivity index assessment
Indices of insulin sensitivity and insulin resistance derived from the fasting glucose and insulin concentration reflect the production of hepatic insulin resistance and basal hepatic glucose. Therefore, we used the homeostasis model assessment (HOMA) to assess the insulin resistance (HOMA-IR) and pancreatic β-cell function (HOMA-β). The method of Matthews et al. 27 was used to estimate, at the baseline using a HOMA-IRderived value, the degree of insulin resistance in each rat. Specifically, a HOMA-IR score was calculated using the follow-ing formula: 28 HOMA-IR = [fasting glucose] × [fasting insulin / 22.5] . When compared to the control, a lower HOMA-IR indicates a high insulin sensitivity, whereas a higher HOMA-IR indicates insulin resistance. The pancreatic β-cell function was calculated using the following formula: HOMA-β = [20 × fasting insulin]/[fasting glucose-3.5]. The Quantitative Insulin Sensitivity Check Index (QUICKI) was calculated using fasting insulin and glucose levels according to the formula by Katz et al.: 29 
Molecular assessment
The total RNA from the liver and skeletal muscle tissues were isolated using a TRIzol Reagent (TRIzol, Invitrogen USA) according to the manufacturer's instructions and then treated with DNase enzymes to remove any genomic DNA contamination. The RNA concentration was measured using a spectrophotometer, and the RNA purity was ascertained from the A260/A280 ratio. The A260/A280 ratio was between 1.8 and 2.0. Total RNA from each sample was converted into cDNA using the Prime Script® RT reagent Kit (TaKaRa® Bio Catalog, Dalian, China), according to the manufacturer's instructions, and the cDNA was used for the reverse transcription-polymerase chain reaction (RT-PCR).
The SYBR Green I RT-PCR Kit (TaKaRa® Bio Catalog, Dalian, China) was used to measure the mRNA expression relative to the insulin receptor substrate (IRS)-1 and IRS-2 expression of the GAPDH (glyceraldehyde-3-phosphate dehydrogenase) control. The rat-specific primers were designed from published GenBank sequences using the Primer Express® Software (Applied Biosystems, Foster City, CA, USA) and were synthesized by Sangon Biological Engineering Co., Ltd (Shanghai, China) ( Table 1) .
For analyses on an ABI PRISM 7500 SDS thermal cycler (Applied Biosystems, Foster City, CA, USA), the reactions were performed with 2.0 µl of first-strand cDNA and 0.4 µl of sense and anti-sense primers in a final volume of 20 µl. The samples were centrifuged briefly and run on the PCR machine using the default fast program (1 cycle at 95°C for 30 s, 40 cycles of 95°C for 5 s and 60°C for 34 s). All PCR reactions were performed in triplicate. The relative gene expression levels in the intestine were determined using the 2 −ΔΔCt method. 
Statistical analysis
All data were analyzed using SPSS software (SPSS Inc., Chicago, IL, USA) and expressed as the mean ± standard error of the mean (mean ± SEM). The data were first analyzed as a randomized design with individual rats as the random factor to examine the overall effect of the treatments. If differences in the treatment were detected by variance (ANOVA), the significance of the differences among the treatments was determined by Duncan's multiple range tests. Significance was considered as the probability of P < 0.05.
Results
Changes in serum glucose and serum insulin levels
The results of serum glucose and serum insulin levels are shown in Table 2 . The serum glucose level and insulin content were significantly increased (P < 0.05) in the phoxim-treated group compared with those in the control group. However, vitamin E supplementation for 28 days partially restored the blood glucose level as compared to that of the phoxim-treated animals (P < 0.05). Vitamin E supplementation did not significantly (P > 0.05) decrease the serum insulin content compared to that in phoxim-treated animals.
Changes in serum triglycerides, cholesterol, HDL-cholesterol and LDL-cholesterol levels
The levels of metabolic biomarkers are shown in Table 2 . There were no significant differences (P > 0.05) in serum triglycerides and LDL-cholesterol between the groups. With regards to serum lipids, phoxim exposure observably increased the TC level and decreased the HDL-cholesterol level compared to those in the control group (P < 0.05). There was a significant decrease in the serum TC level and an increase of HDL-cholesterol values in the vitamin E supplement group when compared to the phoxim-treated group (P < 0.05).
Changes in the glycogen content of liver and skeletal muscles Table 3 shows the results of glycogen contents in the liver and skeletal muscles. Both the hepatic glycogen content and muscular glycogen content decreased significantly (P < 0.05) in the phoxim-treated group in comparison with the control group, while the hepatic glycogen content and muscular glycogen content increased significantly (P < 0.05) in vitamin E-treated rats when compared to phoxim-treated rats.
Glucose and insulin tolerance tests
OGTT was performed on rats that had fasted for 12 hours and received oral administration of 2 g glucose per kg of body weight. As seen in Fig. 1 , the fasting glucose levels showed no significant difference between the groups. After the glucose load, there was no significant difference in blood glucose levels measured at 30 min. However, the blood glucose levels were significantly elevated in the rats exposed to phoxim after 30, 60, 90, 120 and 180 min (P < 0.05). The glucose levels among the control and vitamin E-treated rats returned to normalcy at the end of 3 h, suggesting normal glucose tolerance, while the rats exposed to phoxim showed higher levels (P < 0.05) of glucose at the end of 3 hours, indicating the development of insulin resistance. At the same time, vitamin E supplementation significantly (P < 0.05) decreased the glucose levels compared to those in the phoxim-treated rats. ITT (0.75 U insulin per kg of body weight) performed on rats that had fasted for 6 hours were consistent with the occurrence of overall decreased insulin sensitivity. The glucose-low- 
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Toxicology Research ering effect of insulin was significantly impaired in rats treated with phoxim at 30, 45 and 60 min compared with the control group (P < 0.05). However, vitamin E-supplemented rats displayed significantly (P < 0.05) relieved impairment compared to the phoxim-treated rats (Fig. 2 ).
Glucose and insulin tolerance tests
Changes in the insulin resistance and insulin sensitivity indices. The results of insulin resistance and insulin sensitivity indices are shown in Table 4 . Phoxim exposure enhances the insulin resistance and decreases the insulin sensitivity. There was a statistically significant increase (P < 0.05) in the mean values of HOMA-IR and HOMA-β between the phoxim-treated group and the control group. Meanwhile, the QUICKI was significantly decreased (P < 0.05) after phoxim exposure. Almost no difference (P > 0.05) was found between the vitamin E plus phoxim supplemented rats and phoxim-only rats.
Changes in hexokinase activity. The activities of hexokinase of the liver and skeletal muscles are shown in Table 5 . The activity of liver hexokinase was significantly (P < 0.05) increased in phoxim-treated rats. Treatment with vitamin E controlled the increased hexokinase activity (P < 0.05).
Changes in IRS-1 and IRS-2 expression in liver and skeletal muscles. The mRNA expression of the liver and skeletal muscles IRS-1and IRS-2 is shown in Fig. 3 . Phoxim significantly down-regulated (P < 0.05) the IRS-2 mRNA expression in the liver and skeletal muscles. Vitamin E supplementation did not significantly increase (P > 0.05) the mRNA level of liver IRS-2 after phoxim exposure. No difference (P > 0.05) was found in the experimental groups for the mRNA expression of IRS-1.
Discussion
Epidemiologic research on acute and chronic toxicity of OPs indicates that they are highly toxic to mammals. 4 Several studies have reported the impact of OP insecticides on the dis-turbance of glucose metabolism and the risk of type 2 diabetes. [30] [31] [32] In a previous study, the chronic exposure to phoxim resulted in an enhanced lipid peroxidation on SD rats and lesions of structures in the liver. 33 The present study revealed that chronic exposure to phoxim was associated with concomitant increases of glycaemia and insulinemia. The mechanisms involved in the blood glucose alterations following the exposure to OPs have been under investigation in recent years since hyperglycaemia is one of the prominent side effects of OP poisoning in rats and humans. 34, 35 Our results show that hyperglycaemia as an outcome of chronic exposure to phoxim is due to insulin resistance. Insulin resistance in the phoxim-treated rats was confirmed by HOMA. According to our study, the chronic administration of phoxim increased the HOMA-IR and HOMA-β indices, while at the same time reducing the QUICKI when compared to those of the control, which resulted in insulin resistance accompanied by a decrease in the peripheral insulin sensitivity. Numerous studies have shown that OPs can induce a kind of insulin resistance. 32, 36 At the cellular and molecular levels, the insulin resistance has been explained by the progressive decline in insulin action and the alteration of signaling pathways. The mechanism for hepatic insulin resistance is assessed by the determination of the expression of enzymes involved in glycogenolysis and gluconeogenesis pathways.
The results from the serum lipid status of rats treated with phoxim showed increased concentrations of serum triglycerides (TG), cholesterol and decreased HDL, whereas the LDL was unchanged. Numerous studies have reported a disruption of lipid metabolism in experimental animals exposed to OPs. Acute administration of malathion increases the serum levels of triglycerides, total cholesterol and LDL. 31 Similarly, acute administration of chlorpyrifos increased the serum LDL, VLDL and triglyceride rates. 37 Administration of dichlorvos for 4and 7-weeks periods increased the rate of total serum cholesterol. 38 Lipid abnormalities play an important role in the 
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Toxicol. Res., 2018, 7, 201-210 | 205 development of atherosclerosis in type 2 diabetic patients. 39 In this study, phoxim caused an increase in the total cholesterol level. Increased serum cholesterol can be attributed to the effects of the pesticide on the permeability of liver cell membranes. 40 Patients with type 2 diabetes feature important modification of both LDL and HDL particles which are likely to play important roles in the development of atherosclerosis. Type 2 diabetes is associated with decreased serum HDL cholesterol levels related to the reduction of the HDL 2 subtraction. The decrease in HDL cholesterol, noted in patients with type 2 diabetes, is due to the increased catabolism of HDL particles, which has been demonstrated by in vivo kinetic studies. 41 The increased HDL catabolism related to the insulin-resistant state had been proven in obese insulin resistant non-diabetic patients. 42 Although previous studies showed that OPs induced an increased LDL cholesterol, in the present study, no difference was observed after being exposed to phoxim. Indeed, it has been shown in vivo in which type 2 diabetic patients feature similar LDL cholesterol values to normolipidemic non-diabetic controls, a significant 28% reduction of LDL catabolism associated with reduced LDL production. 43 Insulin resistance is a characteristic feature of syndrome X, and type 2 diabetes mellitus and can be defined as a decreased ability of target tissues such as fat, liver and skeletal muscles to respond normally to insulin. The liver and skeletal muscles are the most important sites of insulin-mediated glucose disposal. Research has reported that the activation of the glycogenolysis pathway is a possible mechanism involved in hyperglycaemia caused by OPs. 44 Exposure to malathion showed a relationship between the increased serum glucose levels and decreased hepatic glycogen levels, indicating that the glycogenolysis pathway plays an important role in hyperglycaemia.
In the present study, our results showed that hyperglycaemia induced by phoxim was associated with the activation of the glycogenolysis pathway in the liver and skeletal muscles.
Phoxim caused an increase in the hexokinase activity in rat livers. The same result was reported in malathion-treated rats. 45 The important role of hexokinase is that guarantees a generous offer of glucose 6-phosphorylation by phosphorylation. Glucose 6-phosphorylation is the necessary precursor for glycogenesis and glycolysis. This phosphorylation guarantees the balance of glucose concentrations between the inside and outside of living cells, and provides glucose 6-phosphorylation for other metabolic pathways. 46 After exposure to phoxim, this balance was disturbed, followed by increased serum glucose and decreased hepatic glycogen levels. Hexokinase normally operates in a state of partial inhibition by glucose 6-phosphorylation, while the increased glucose concentration partially releases hexokinase from inhibition by glucose 6-phosphorylation. 47 However, the same decreased glycogen content was observed in the skeletal muscles of rats exposed to phoxim. Interestingly, there was no difference between the hexokinase activity of the skeletal muscle and that of control rats. Rats have a lower skeletal muscle glycogen content and appear to rely more on extra muscular glucose than glycogen for fuel during exercise. This has been verified in rats that do not express muscle glycogen synthase, but still have normal endurance capacity. 48 Another study reported that the overexpression of hexokinase did not improve the insulinstimulated muscle glucose uptake. 49 IRS molecules are critical elements that interact with the transmission of signals from multiple receptors 50 and play an important role in maintaining the cell growth, division and metabolism as key mediators of insulin signaling systems. IRS-1 plays a key role in proximal insulin signaling and has been extensively studied in this respect, although, the phoximtreated rats have a higher fasting serum glucose and insulin level. In this experiment, no difference was found for mRNA expression of IRS-1. According to previous reports, there was no evidence for association with type 2 diabetes for the two main IRS-1 variants (P512A and G971R) in statistical experiments. 51 These reports also demonstrated that the down-regulated expression or phosphorylation of IRS-1 can lead to insulin resistance. 52 Normally, insulin, via insulin receptors, is able to induce the phosphorylation of several sites in IRS-1 very orderly and controlled time, allowing a very precise 
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Toxicology Research control during insulin action. 53 Insulin stimulates the tyrosine phosphorylation of IRS-1, followed by serine phosphorylation to inhibit insulin signalling. 54 This negative feedback of insulin helps in maintaining normal glucose levels. OPs have been known to induce inflammatory and oxidative stress conditions and therefore over-activate the serine kinase, leading to the inactivation of IRS-1 and promotion of insulin resistance. 7 Based on our results and those of previous reports, we believe that the phoxim-induced insulin resistance does not result in down-regulated expression but abnormal phosphorylation of IRS-1. IRS-2 plays a central role in preserving the insulin action in multiple cell types, while the reduction of IRS-2 expression and/or function may be a fundamental cause for the development of insulin resistance, obesity, β cell failure, and type 2 diabetes. 55 IRS-2 deficient mice displayed both impaired peripheral insulin signaling and pancreatic β cell function, and showed progressive deterioration of glucose homeostasis because of the insulin resistance in the liver and skeletal muscles. 56 Our results have shown that phoxim resulted in the down-regulated expression of IRS-2. This is the first evidence of an association between OPs and IRS-2 mRNA expression.
The results of this study show that vitamin E can reduce the high blood glucose levels and insulin after exposure to phoxim. A previous study has also shown that vitamin E reduces the blood glucose levels in diabetic animals. 57 The mechanism by which vitamin E inhibits the induction of hyperglycaemia and hyperinsulinemia is not yet understood. Vitamin E as an antioxidant may help in the clearance of free radicals induced by phoxim. Vitamin E may also promote the absorption or uptake of glucose from the intestine and cells. Meanwhile, vitamin E has the ability to resist stress situations, which is the main factor responsible for the early hyperglycaemia induced by phoxim. 7 Another study also suggest that the serum concentration of vitamin E among humans may improve the insulin sensitivity and potentially, pancreatic compensation for insulin resistance. 58 This may explain the lower serum insulin levels compared to those in phoxim-treated rats. The results of this study show that vitamin E can improve the body weight and feed intake in phoxim plus vitamin E-treated rats. This was similar to the result that the protective effects vitamins E exhibits against dichlorvos-induced toxicity. 38 The feeding behavior is mainly controlled by the nervous system, which is one of the primary targets of phoxim toxicity in animals. A previous study reported that elevated cystathionine and homocysteine levels suggest a deficit in cysteine biogenesis and, consequently, the capacity to replenish glutathione. Vitamin E administration was able to restore the cysteine metabolism due to chlorpyrifos toxicity in Atlantic salmon. 24 A decreased liver hexokinase activity and increased glycogen contents in the liver and skeletal muscles were observed for rats supplied with vitamin E after exposure to phoxim. However Olsvik et al. 24 reported that vitamin E supplementation in the presence of chlorpyrifos was unable to restore the glycogen metabolite levels. In this study, an increased feed intake and lower serum glucose levels were observed. The increased glyco-gen content may be a result of enough energy in the body. The alterations observed in this study regarding lipid metabolism and lipid proteins indicate that vitamin E can remit the damage induced by phoxim. Aldana et al. 19 also reported the same effect of vitamin E on cypermethrin induced liver toxicity. Vitamin E forms a small aggregation in the lipid bilayer, making it possible to induce a protective effect when administered before the insecticide. It is suggested that vitamin E acts by blocking the formation of lipoperoxides, and not forming a covalent bond with free radicals. 59 Vitamin E did not reduce the insulin resistance or improve the insulin sensitivity after phoxim exposure, according to the results of the HOMA-IR, HOMA-β indices and QUICKI. As reviewed by Lasram et al. 7 the mechanisms of insulin resistance induced by OPs are complex. OPs cause oxidative stress, which leads to impairments in the metabolism of carbohydrates. As an antioxidant, vitamin E has beneficial effects on insulin resistance. On the other hand, OPs also promote pro-inflammatory cytokines which are responsible for c-Jun N-terminal kinase and inhibitor kB kinase pathway activation. This pathway activation inhibits the phosphorylation of IRS-1, and results in insulin resistance. To date, there is no evidence that vitamin E has had an effect on reducing pro-inflammatory cytokines. At the same time, vitamin E did not show a beneficial effect on IRS-2 mRNA expression after exposure to phoxim.
Conclusion
The results of the current study suggest that, phoxim causes insulin resistance by hyperglycaemia, hyperinsulinism and hyperlipidemia. The glycogenolysis and gluconeogenesis pathways were also disturbed after exposure to phoxim. The downregulated expression of mRNA of IRS-2 was first presented in terms of the effect of OPs on insulin resistance. Our data show that vitamin E does have a beneficial effect on the growth performance and serum biochemistry levels. However vitamin E supplementation partially alleviated insulin resistance and partially improved the molecular changes induced by phoxim. Further studies need to be conducted on the beneficial effects of prevention versus treatment of OP-induced changes in glucose homeostasis.
